Factors influencing axillary node metastasis in breast cancer

Tumori

Volumn 92, Issue 5, 2006, Pages 416-422

  Çetintaş, Sibel Kahraman ^a   Kurt, Meral ^a   Özkan, Lütfi ^a   Engin, Kayihan ^a   Gökgöz, Şehsuvar ^a   Taşdelen, Ismet ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Axillary lymph node involvement; Breast cancer; Prognostic factors

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; HIGH RISK POPULATION; HUMAN; INTRADUCTAL CARCINOMA; LOGISTIC REGRESSION ANALYSIS; LYMPH NODE METASTASIS; LYMPHANGIOMA; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; NIPPLE; PROGNOSIS; RANK SUM TEST; RISK ASSESSMENT; RISK FACTOR; SKIN CANCER;

EID: 33845267263     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160609200509     Document Type: Article

References (57)

1. Cotlar AM, Dubose JJ, Rose DM: History of surgery for breast cancer: Radical to the sublime. Curr Surg, 60: 329-337, 2003.
2. Fisher B, Redmont C, Fisher ER: The contribution of recent NSABP clinical trials of primary breast cancer therapy to an understanding of tumor biology - an overview of findings. Cancer, 46: 1009-1025, 1980.
3. Atkins HJ, Hayward JL, Klugman DJ, Wayte AB: Treatment of early breast cancer: A report after ten years of a clinical trial. Br Med J, 2: 423-429, 1972.
4. Sarrazin D, Le M, Rouesse J, Contesso G, Petit JY, Lacour J, Viguier J, Hill C: Conservative treatment versus mastectomy in breast cancer tumors with macroscopic diameter of 20 millimeters or less. The experience of the Institut Gustave-Roussy. Cancer, 53: 1209-1213, 1984.
5. Veronesi U, Saccozzi R, Del Vecchio M, Banfi A, Clemente C, De Lena M, Gallus G, Greco M, Luini A, Marubini E, Muscolino G, Rilke F, Salvadori B, Zecchini A, Zucali R: Comparing radical mastectomy with quadrantectomy, axillary dissection and radiotherapy in patients with small cancers of the breast. N Engl J Med, 305: 6-11, 1981.
6. NIH Consensus Development Conference on the Treatment of Early-Stage Breast Cancer. Bethesda, Maryland, June 18-21, 1990. J Natl Cancer Inst Monogr, 11: 1-187, 1992.
7. Adjuvant Therapy for Breast Cancer. NIH Consens Statement, 17: 1-35, 2000.
8. Truong PT, Olivotto IA, Whelan TJ, Levine M: Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy. CMAJ, 170: 1263-1273, 2004.
9. Recht A, Edge SB, Solin LJ, Robinson DS, Estabrook A, Fine RE, Fleming GF, Formenti S, Hudis C, Kirshner JJ, Krause DA, Kuske RR, Langer AS, Sledge GW Jr, Whelan TJ, Pfister DG: Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol, 19: 1539-1569, 2001.
10. Giuliano AE, Kirgan DM, Guenther JM, Morton DL: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg, 220: 391-401, 1994.
11. Veronesi U, Galimberti V, Mariani L, Gatti G, Paganelli G, Viale G, Zurrida S, Veronesi P, Intra M, Gennari R, Rita Vento A, Luini A, Tullii M, Bassani G, Rotmensz N: Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissection. Eur J Cancer, 41: 231-237, 2005.
12. Kepple J, Van Zee KJ, Dowlatshahi K, Henry-Tillman RS, Israel PZ, Klimberg S: Minimally invasive breast surgery. J Am Coll Surg, 961-975, 2004.
13. Zavagno G, Carcoforo P, Franchini Z, Renier M, Barutta L, De Salvo GL, Maravegias K, Capitanio G, Nitti D, Lise M: Axillary recurrence after negative sentinel lymph node biopsy without axillary dissection: a study on 479 breast cancer patients. Eur J Surg Oncol, 31: 715-720, 2005.
14. Wood WC: The future of surgery in the treatment of breast cancer. Breast, 12: 472-474, 2003.
15. Chagpar AB, Martin RC, Scoggins CR, Carlson DJ, Laidley AL, El-Eid SE, McGlothin TQ, Noyes RD, Ley PB, Tuttle TM, McMasters KM: Factors predicting failure to identify a sentinel lymph node in breast cancer. Surgery, 138: 56-63, 2005.
16. Nieweg OE, Bartelink H: Implications of lymphatic mapping for staging and adjuvant treatment of patients with breast cancer. Eur J Cancer, 40: 179-181, 2004.
17. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, Intra M, Veronesi P, Robertson C, Maisonneuve P, Renne G, De Cicco C, De Lucia F, Gennari R: A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med, 7: 603-605, 2003.
18. Spratt JS, Donegan WL: Screening and follow-up. In: Cancer of the breast, Donegan WL, Spratt JS (Eds), pp 269-286, WB Saunders, Philadelphia, 1995.
19. Foster RS, Costanza MC: Breast self examination practices and breast cancer survival. Cancer, 53: 167, 1984.
20. Overgaard J: Management of axilla in breast cancer. Implication for diagnosis, prognosis, treatment, and morbidity. Acta Oncol, 39: 259-260, 2000.
21. Peto R, Boreham J, Clarke M, Davies C, Beral V: UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years. Lancet, 355: 1822, 2000.
22. Koscielny S, Le MG, Tubiana M: The natural history of human breast cancer. The relationship between involvement of axillary lymph nodes and initiation of distant metastasis. Br J Cancer, 59: 775-782, 1989.
23. Levitt SH: Approaching the axilla in breast cancer. Increasing survival, decreasing morbidity. Acta Oncol, 39: 261-264, 2000.
24. Axelsson CK, Rank F, Blichert-Toft M, Mouridsen HT, Jensen MB: Impact of axillary dissection on staging and regional control in breast tumors ≤10 mm - the DBCG experience. Acta Oncol, 39: 283-289, 2000.
25. Arnesson LG, Ahlgren J: Omitting axillary surgery for low-risk breast cancer patients. A Swedish prospective cohort study. Acta Oncol, 39: 291-294, 2000.
26. Veronesi U: Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet, 349: 1864-1867, 1997.
27. Kingsmore DB, Hole DJ, Gillis CR, George WD: Axillary recurrence in breast cancer. Eur J Surg Oncol, 31: 226-231, 2005.
28. Editorial commentary: Axillary dissection in breast cancer update. The Breast 2005, 14: 83-84, 2005.
29. Fourguet A, Campana F, Zafrani B, Mosseri V, Vielh P, Durand JC, Vilcoq JR: Prognostic factors of breast cancer: 25 year follow up. Int J Radiat Oncol Biol Phys, 17: 719-725, 1989.
30. Mansel RE, Khonji NI, Clarke D: History, present status and future of sentinel node biopsy in breast cancer. The Mary Beves Lecture. Acta Oncol, 39: 265-268, 2000.
31. Blichert-Toft M: Axillary surgery in breast cancer management. Background, incidence and extent of nodal spread, extent of surgery and accurate axillary staging, surgical procedures. Acta Oncol, 39: 269-275, 2000.
32. Arriagada R, Le MG: Adjuvant radiotherapy in breast cancer. The treatment of lymph node areas. Acta Oncol, 39: 295-305, 2000.
33. Johansen J, Overgaard J, Blichert-Toft, Overgaard M: Treatment morbidity associated with the management of axilla in breast-conserving therapy. Acta Oncol, 39: 349-354, 2000.
34. Hojris I, Andersen J, Overgaard J, Overgaard M: Late treatment-related morbidity in breast cancer patients randomized to postmastectomy radiotherapy and systemic treatment versus systemic treatment alone. Acta Oncol, 39: 355-372, 2000.
35. Johansson S, Svensson H, Larsson LG, Denekamp J: Brachial plexopathy after postoperative radiotherapy of breast cancer patients. Acta Oncol, 39: 373-382, 2000.
36. Shahar KH, Hunt KK, Thames HD, Ross MI, Perkins GH, Kuerer HM, Strom EA McNeese MD, Meriç F, Schechter NR, Sahin AA, Middleton LP, Buchholz TA: Factors predictive of having four or more positive axillary lymph nodes in patients with positive sentinel lymph nodes: implications for selection of radiation fields. Int J Radiat Oncol Biol Phys, 59: 1074-1079, 2004.
37. Soni NK, Carmalt HL, Gillett DJ, Spillane AJ: Evaluation of a breast cancer nomogram for prediction of non-sentinel lymph node positivity. Eur J Surg Oncol, 31: 958-964, 2005.
38. Veronesi U, Luini A, Galimberti V, Marchini S, Sacchini V, Rilke F: Extent of metastatic axillary involvement in 1446 cases of breast cancer. Eur J Surg Oncol, 16: 127-133, 1990.
39. Mustafa IA, Bland KI: Indications for axillary dissection in T1 breast cancer. Ann Surg Oncol, 5: 4-8, 1998.
40. Port ER, Tan LK, Borgen PI, van Zee KJ: Incidence of axillary lymph node metastases in T1a and T1b breast carcinoma. Ann Surg Oncol, 5: 23-27, 1998.
41. Ravdin PM, De Laurentiis M, Vendely T, Clark GMI: Prediction of axillary node status in breast cancer patients by use of prognostic indicators. J Natl Cancer Inst, 86: 1771-1775, 1994.
42. Wong JS, O'Neill A, Recht A, Schnitt S, Connolly JL, Silver B, Harris JR: The relationship between lymphatic vessel invasion, tumor size, and pathologic nodal status: Can we predict who can avoid a third field in the absence of axillary dissection? Int J Radiat Oncol Biol Phys, 48: 133-137, 2000.
43. Louis-Sylvestre C, Clough K, Asselain B, Vilcog JR, Salmon RI, Campana F, Fourquet A: Axillary treatment in conservative management of operable breast cancer: Dissection or radiotherapy? Results of a randomized study with 15 years of follow-up. J Clin Oncol, 22: 97-101, 2004.
44. Katz A, Strom EA, Buchholz TA, Thames HD, Smith CD, Jhingran A, Hortobagyi G, Buzdar AU, Theriault R, Singletary E, McNeese MD: Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation. J Clin Oncol, 18: 2817-2827, 2000.
45. Early Breast Cancer Trialists' Collaborative Group: Polychemotherapy for early breast cancer: An overview of the randomized trials. Lancet, 352: 930-942, 1998.
46. Buzdar AU: Data from the Arimidex, tamoxifen, alone or in combination (ATAC) trial: implications for use of aromatase inhibitors in 2003. Clin Cancer Res, 10: 355-361, 2004.
47. Polednak AP: Chemotherapy of nonelderly breast cancer patients by poverty-rate of area of residence in Connecticut. Breast Cancer Res Treat, 83: 245-248, 2004.
48. Iyer RV, Hanlon A, Fowble B, Freedman G, Nicolaou N, Anderson P, Hoffman J, Sigurdson E, Boraas M, Torosian M: Accuracy of the extent of axillary nodal positivity related to primary tumor size, number of involved nodes, and number of nodes examined. Int J Radiat Oncol Biol Phys, 47: 1177-1183, 2000.
49. Truong PT, Olivotto IA, Kader HA, Panades M, Speers CH, Berthelet E: Selecting breast cancer patients with T1-2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy. Int J Radiat Oncol Biol Phys, 61: 1337-1347, 2005.
50. Kuijt GP, Voogd AC, van de Poll-Franse LV, Scheijmans LJEE, van Beek MWPM, Roumen RMH: The prognostic significance of axillary lymph-node micrometastases in breast cancer patients. Eur J Surg Oncol, 31: 500-505, 2005.
51. Galper S, Recth A, Silver B, Bernerdo MVP, Gelman R, Wong JS, Schnitt S, Connolly JL, Harris JR: Is radiation alone adequate treatment to the axilla for patients with limited axillary surgery? Implications for treatment after a positive sentinel node biopsy. Int J Radiat Oncol Biol Phys, 48: 125-132, 2000.
52. Davis BW, Gelber R, Goldhirsch A, Hartmann WH, Hollaway L, Russell I, Rudenstam CM: Prognostic significance of peritumoral vessel invasion in clinic trials of adjuvant therapy for breast cancer with axillary lymph node metastasis. Hum Pathol, 16: 1212-1218, 1985.
53. Holmberg L, Lindgren A, Norden T, Adami HO, Bergstrom R: Age as determinant of axillary nodal involvement in invasive breast cancer. Acta Oncol, 31: 533-538, 1992.
54. De Laurentiis M, Gallo C, De Placido S, Perrone F, Pettinato G, Petrella G, Carlomagno C, Panico L, Delrio P, Bianco AR: A predictive index of axillary nodal involvement in operable breast cancer. Br J Cancer, 73: 1241-1247, 1996.
55. Kurtz JM, Spitalier JM, Amalric R, Brandone H, Ayme Y, Hans D: Mammary recurrence in women younger than forty. Int J Radiat Oncol Biol Phys, 15: 271-276, 1998.
56. McCready DR, Chapman CA, Hanna WM, Kahn HJ, Murray D, Fish EB, Trudeau ME, Andrulis IL, Lickley HL: Factors affecting distant disease-free survival for primary invasive breast cancer: use of a log-normal survival model. Ann Surg Oncol, 7: 416-426, 2000.
57. Gebrim LH, de Lima GR, Gianotti Filho O, Barreto E, Baracat FF, Grabert HH: Prognostic value of the histopathologic private characteristics of breast cancer in patients with no axillary lymph node involvement. Sao Paulo Med J, 112: 522-528, 1994.